Additional indications of interest that are being actively pursued by Claris, supported by preclinical and clinical data, include limbal stem cell deficiency and pre-existing corneal scar. Future potential indications include corneal injury, corneal ulcers, chemical burns, and persistent epithelial defects.
>>725
クラリスHPの資金調達に関する記事に、corneal scarについても載っていました。
適応症の候補は、眼科領域だけでも他にいろいろありそうですね。
Additional indications of interest that are being actively pursued by Claris, supported by preclinical and clinical data, include limbal stem cell deficiency and pre-existing corneal scar. Future potential indications include corneal injury, corneal ulcers, chemical burns, and persistent epithelial defects.